SEC Form 4 · accession 0001232524-15-000076
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Seamus Mulligan
Director
Period of report
Mar 25, 2015
Accepted (ET)
Mar 27, 2015 · 6:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF2 | Mar 25, 2015 | S | 3,455 | $172.1278 | D | 1,203,750 | D | |
| Ordinary SharesF3 | Mar 25, 2015 | S | 13,801 | $172.9954 | D | 1,189,949 | D | |
| Ordinary SharesF4 | Mar 25, 2015 | S | 10,977 | $173.818 | D | 1,178,972 | D | |
| Ordinary SharesF5 | Mar 25, 2015 | S | 8,171 | $174.8725 | D | 1,170,801 | D | |
| Ordinary SharesF6 | Mar 25, 2015 | S | 4,300 | $176.071 | D | 1,166,501 | D | |
| Ordinary SharesF7 | Mar 25, 2015 | S | 4,300 | $177.0804 | D | 1,162,201 | D | |
| Ordinary SharesF8 | Mar 25, 2015 | S | 4,321 | $178.1333 | D | 1,157,880 | D | |
| Ordinary SharesF9 | Mar 25, 2015 | S | 200 | $179.04 | D | 1,157,680 | D | |
| Ordinary Shares | Mar 25, 2015 | S | 475 | $181.80 | D | 1,157,205 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.36 to $172.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172.39 to $173.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $173.3951 to $174.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $174.41 to $175.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.50 to $176.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F7The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.57 to $177.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F8The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.60 to $178.5671, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F9The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.84 to $179.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.